Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Fenfluramine in Lennox Gastaut Epilepsy
NCT02655198Phase 2Completed
- Sponsor
- KU Leuven
- Start
- Jan 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenfluramine in Lennox-Gastaut syndrome (LGS), sponsored by KU Leuven. Started Jan 2016; status: completed.
02
Drugs
fenfluramine
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT02655198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655198.